Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guillaume Beaudoin

Showing results (11-20 of 68) with videos related to

Pageof 7
Sort By:
ACS Applied Bio Materials|December 18, 2023
Chlorophyllin-Containing Copolymers and Their Responsive PropertiesXuemin Liu, Guillaume Beaudoin, Hu Zhang, et al.
Viruses|October 29, 2020
Antibody Binding to SARS-CoV-2 S Glycoprotein Correlates with but Does Not Predict NeutralizationShilei Ding, Annemarie Laumaea, Mehdi Benlarbi, et al.
ACS Medicinal Chemistry Letters|November 20, 2024
Optimization of a Piperidine CD4-Mimetic Scaffold Sensitizing HIV-1 Infected Cells to Antibody-Dependent Cellular CytotoxicityDaniel Lee, Ling Niu, Shilei Ding, et al.
Viruses|June 28, 2023
A Recent SARS-CoV-2 Infection Enhances Antibody-Dependent Cellular Cytotoxicity against Several Omicron Subvariants following a Fourth mRNA Vaccine DoseGuillaume Beaudoin-Bussières, Alexandra Tauzin, Katrina Dionne, et al.
Vaccines|September 28, 2021
Incorporating the Cluster A and V1V2 Targets into a Minimal Structural Unit of the HIV-1 Envelope to Elicit a Cross-Clade Response with Potent Fc-Effector FunctionsRebekah Sherburn, William D Tolbert, Suneetha Gottumukkala, et al.
Viruses|May 28, 2025
Impact of Vaccine-Elicited Anti-Spike IgG4 Antibodies on Fc-Effector Functions Against SARS-CoV-2Katrina Dionne, Alexandra Tauzin, Étienne Bélanger, et al.
Scientific Reports|November 17, 2022
Association between SARS-CoV-2 RNAemia and dysregulated immune response in acutely ill hospitalized COVID-19 patientsRoberta Rovito, Valeria Bono, Matteo Augello, et al.
Virology|March 4, 2025
Longitudinal humoral immunity against SARS-CoV-2 Spike following infection in individuals from CameroonMehdi Benlarbi, Dell-Dylan Kenfack, Katrina Dionne, et al.
Viruses|July 27, 2024
NTB-A and 2B4 Natural Killer Cell Receptors Modulate the Capacity of a Cocktail of Non-Neutralizing Antibodies and a Small CD4-Mimetic to Eliminate HIV-1-Infected Cells by Antibody-Dependent Cellular CytotoxicityLorie Marchitto, Alexandra Tauzin, Mehdi Benlarbi, et al.
Cell Reports. Medicine|December 30, 2022
The Fc-effector function of COVID-19 convalescent plasma contributes to SARS-CoV-2 treatment efficacy in miceIrfan Ullah, Guillaume Beaudoin-Bussières, Kelly Symmes, et al.
Pageof 7

Showing results (11-20 of 68) with videos related to

Sort By:
Pageof 7
ACS Applied Bio Materials|December 18, 2023
Chlorophyllin-Containing Copolymers and Their Responsive PropertiesXuemin Liu, Guillaume Beaudoin, Hu Zhang, et al.
Viruses|October 29, 2020
Antibody Binding to SARS-CoV-2 S Glycoprotein Correlates with but Does Not Predict NeutralizationShilei Ding, Annemarie Laumaea, Mehdi Benlarbi, et al.
ACS Medicinal Chemistry Letters|November 20, 2024
Optimization of a Piperidine CD4-Mimetic Scaffold Sensitizing HIV-1 Infected Cells to Antibody-Dependent Cellular CytotoxicityDaniel Lee, Ling Niu, Shilei Ding, et al.
Viruses|June 28, 2023
A Recent SARS-CoV-2 Infection Enhances Antibody-Dependent Cellular Cytotoxicity against Several Omicron Subvariants following a Fourth mRNA Vaccine DoseGuillaume Beaudoin-Bussières, Alexandra Tauzin, Katrina Dionne, et al.
Vaccines|September 28, 2021
Incorporating the Cluster A and V1V2 Targets into a Minimal Structural Unit of the HIV-1 Envelope to Elicit a Cross-Clade Response with Potent Fc-Effector FunctionsRebekah Sherburn, William D Tolbert, Suneetha Gottumukkala, et al.
Viruses|May 28, 2025
Impact of Vaccine-Elicited Anti-Spike IgG4 Antibodies on Fc-Effector Functions Against SARS-CoV-2Katrina Dionne, Alexandra Tauzin, Étienne Bélanger, et al.
Scientific Reports|November 17, 2022
Association between SARS-CoV-2 RNAemia and dysregulated immune response in acutely ill hospitalized COVID-19 patientsRoberta Rovito, Valeria Bono, Matteo Augello, et al.
Virology|March 4, 2025
Longitudinal humoral immunity against SARS-CoV-2 Spike following infection in individuals from CameroonMehdi Benlarbi, Dell-Dylan Kenfack, Katrina Dionne, et al.
Viruses|July 27, 2024
NTB-A and 2B4 Natural Killer Cell Receptors Modulate the Capacity of a Cocktail of Non-Neutralizing Antibodies and a Small CD4-Mimetic to Eliminate HIV-1-Infected Cells by Antibody-Dependent Cellular CytotoxicityLorie Marchitto, Alexandra Tauzin, Mehdi Benlarbi, et al.
Cell Reports. Medicine|December 30, 2022
The Fc-effector function of COVID-19 convalescent plasma contributes to SARS-CoV-2 treatment efficacy in miceIrfan Ullah, Guillaume Beaudoin-Bussières, Kelly Symmes, et al.
Pageof 7